The first breathing tube to reduce the risk of pneumonia in patients on ventilators has won federal approval, according to the U.S. Food and Drug Administration (FDA). The Agento endotracheal tube, by C.R. Bard Inc., of Murray Hill, N.J., has a thin coat of silver, which is known to have antimicrobial properties. In a clinical trial comparing it with an uncoated tube, the percentage of patients who developed ventilator-associated pneumonia was 4.8% vs. 7.5%, according to Daniel Schultz, MD, director of the FDA’s Center for Devices and Radiological Health.
Daily News: Tube Reduces Pneumonia
About the Author: Nurse.com
- July 1st, 2016 | 0 Comments
- December 10th, 2015 | 9 Comments
- November 9th, 2015 | 0 Comments